87 related articles for article (PubMed ID: 31257659)
1. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
2. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
3. Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.
Xiang H; Li H; Ge W; Wu W; Gao M; Wang W; Hong L; Jiang D; Zhang C
Mol Biol Rep; 2013 Nov; 40(11):6371-7. PubMed ID: 24078094
[TBL] [Abstract][Full Text] [Related]
4. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
[TBL] [Abstract][Full Text] [Related]
5. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
6. Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer.
Shao HB; Ren K; Gao SL; Zou JG; Mi YY; Zhang LF; Zuo L; Okada A; Yasui T
Aging (Albany NY); 2018 Jul; 10(7):1776-1788. PubMed ID: 30064122
[TBL] [Abstract][Full Text] [Related]
7. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.
Yan Y; Xu J; Xu B; Wen Q; Zhou J; Zhang L; Zuo L; Lv G; Shi Y
J Clin Lab Anal; 2020 Sep; 34(9):e23403. PubMed ID: 32488882
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
9. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
10. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.
Mao C; Qiu LX; Zhan P; Xue K; Ding H; Du FB; Li J; Chen Q
J Cancer Res Clin Oncol; 2010 Jul; 136(7):975-9. PubMed ID: 20012093
[TBL] [Abstract][Full Text] [Related]
11. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
12. Association of C-reactive protein (CRP) rs1205 and rs2808630 variants and risk of cancer.
Pan HY; Mi YY; Xu K; Zhang Z; Wu H; Zhang W; Yuan W; Shi L; Zhang LF; Zhu LJ; Zuo L
J Cell Physiol; 2020 Nov; 235(11):8571-8584. PubMed ID: 32329054
[TBL] [Abstract][Full Text] [Related]
13.
Zhang M; Liang Q; Zhang L; Hao Z; Zhou J; Zhang L; Fan S; Liang C
Dis Markers; 2018; 2018():1418609. PubMed ID: 29750086
[TBL] [Abstract][Full Text] [Related]
14. Update analysis on the association between Methionine synthase rs1805087 A/G variant and risk of prostate cancer.
Zhang W; Zhang Z; Wu H; Xu K; Yuan W; Mi YY; Shi L; Zuo L; Shi YF
Sci Rep; 2020 Aug; 10(1):13384. PubMed ID: 32770085
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications.
Zhang M; Xiong H; Fang L; Lu W; Wu X; Huang ZS; Wang YQ; Cai ZM; Wu S
Asian Pac J Cancer Prev; 2015; 16(10):4457-63. PubMed ID: 26028114
[TBL] [Abstract][Full Text] [Related]
16. Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer.
Yang Y; Wang W; Zhang L; Zhang S; Liu G; Yu Y; Liao M
Oncotarget; 2016 May; 7(18):25528-34. PubMed ID: 27009866
[TBL] [Abstract][Full Text] [Related]
17. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
Stott-Miller M; Wright JL; Stanford JL
Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
[TBL] [Abstract][Full Text] [Related]
18. Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis.
Zhang M; Huang J; Tan X; Bai J; Wang H; Ge Y; Xiong H; Shi J; Lu W; Lv Z; Liang C
Med Sci Monit; 2015 Oct; 21():3186-96. PubMed ID: 26488500
[TBL] [Abstract][Full Text] [Related]
19. TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis.
Cai Q; Tang Y; Zhang M; Shang Z; Li G; Tian J; Jiang N; Quan C; Niu Y
Tumour Biol; 2014 Jan; 35(1):667-73. PubMed ID: 23975370
[TBL] [Abstract][Full Text] [Related]
20. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
